University of Washington Foundation

Grantee website Seattle, Washington, United States
Purpose
to co-fund the clinical development program of Islatravir for HIV prevention, specifically for the IMPOWER phase 3 efficacy and safety trial among women and adolescent girls in sub-Saharan Africa
Division
Global Health
Date
MARCH 2021
Region served
GLOBAL
Committed amount
$122,264,513
Grant topic
HIV
Duration (months)
76
Grantee location
Seattle, Washington, United States
Program strategy page

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.